BioRestorative Therapies suspends shipments of ExoCR and BioX products for review

IBM reduced its annual revenue growth forecast on Wednesday. The company also missed profit and revenue expectations for the second quarter. This shift occurred as corporate spending moved towards AI data-center gear. IBM’s Z mainframe revenue slumped significantly, impacting overall infrastructure performance. Executives reassured shareholders about long-term mainframe demand despite current challenges.

Puerto Rico’s federally appointed financial regulator said it may revoke a 400-megawatt emergency power contract valued at as much as $5.9 billion over 10 years after a purported bidder said its company’s name and signature were used without authorization.

Following unexpectedly weak US nonfarm payrolls data for July, investors will closely watch the latest inflation readings, housing-market figures, retail sales data and consumer sentiment survey for clues about the strength of the US economy and the Federal Reserve’s next monetary policy move